Amylyx Pharmaceuticals Inc (AMLX)

Retained Earnings

-$836.13M

Quarterly · Period ending: · USD

AMLX logo

AMLX Retained Earnings

Latest reported-$836.13M
AMLX Quarterly Retained Earnings (-$127.50M → -$836.13M)
High-resolution chart · PNG

AMLX retained earnings history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Amylyx Pharmaceuticals Inc Retained Earnings — Quarterly (USD)
Period endingRetained Earnings (USD)
-836,134,000
-792,711,000
-751,427,000
-718,428,000
-684,042,000
-642,599,000
-606,692,000
-569,146,000
-496,442,000
-423,742,000
-304,949,000
-309,680,000
-330,573,000
-352,647,000
-354,220,000
-311,516,000
-257,760,000
-203,693,000
-155,845,000
-127,501,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.